Traxion Sab De Cv Ord Shs GRPOF

TBP SUBS QUANTUM REC'D GMP NOTICE OF COMPLIANCE BY HC

[Humanist]

GREAT NEWS, HOPEFULLY SOON WE'D HEAR THEY WILL BEGIN MANUFACTURING .......

Tetra Bio-Pharma Receives Compliant Rating on Inspection from Health Canada
by @accesswire on 18 Mar 2021, 02:00
    

• Quantum Pharma Inc. is a contract facility operated by Tetra Bio-Pharma Inc
• Quantum Pharma Inc. receives a Notice of Compliant rated inspection

OTTAWA, ON / ACCESSWIRE / March 18, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP)(OTCQB:TBPMF)(FRA:JAM1), a biopharmaceutical pioneer in immunomodulator drug discovery and development announce that its contract manufacturing facility, Quantum Pharma Inc., received a notice of compliance for its Drug Establishment License (DEL) following an audit by the Drug GMP Inspection Program of Health Canada.

Guy Chamberland, CEO and CRO of Tetra Bio-Pharma stated, "This is a major step forward for Tetra. The manufacturing of any prescription drug is a complex operation that takes expertise and dedication to achieve high quality standards."

The facility first obtained the DEL in 2018. Since then, Tetra has continuously improved its quality management system to ensure compliance with Health Canada's GMP requirements. The inspection took place in February 2021 and during this period, Tetra demonstrated to Health Canada that it can manufacture drugs, such as QIXLEEF™, in compliance with the requirements for a prescription drug.

Guy Chamberland, added, "Maintaining a Compliant Rating (C) for a DEL is not an easy task as it is the recognition of the pharmaceutical GMP quality process by Health Canada. We are very proud of the team at Tetra. This is another sign to shareholders that we are committed to working and operating by the rules set by drug regulators like Health Canada and the U.S. Food and Drug Administration and delivering high quality pharmaceutical medications to patients."

About Tetra Bio-Pharma
Tetra Bio-Pharma (TSX:TBP)(OTCQB:TBPMF)(FRA:JAM1) is a biopharmaceutical pioneer in immunomodulator drug discovery and development with a FDA and a Health Canada cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. Our evidence-based scientific approach has enabled us to develop a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. With patients at the core of what we do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing biopharma industry by regulators, physicians and insurance companies. For more information visit: www.tetrabiopharma.com.
Neither the TSX Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Exchange) accepts responsibility for the adequacy or accuracy of this release.
 

[Humanist]

damn market (becasue its in the red) they robbed us off of our due bounce because  we had impt news.  we didnt' get any bounce maybe i nthe afternoon! gl ta

[shortstacked]

The bounce will come... if not today.. tomorrow... or next week... patience on this will pay off.

[shortstacked]

Like always on the tsx, the big boys will drag it down a little to scare off the little fish and take their money... just wait for it.